Viewing Study NCT00398957


Ignite Creation Date: 2025-12-24 @ 6:48 PM
Ignite Modification Date: 2026-01-02 @ 12:50 PM
Study NCT ID: NCT00398957
Status: COMPLETED
Last Update Posted: 2010-04-27
First Post: 2006-11-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Open-Label Evaluation of the Dose Proportionality of OROS� Hydromorphone HCL Tablets 8mg, 16mg, 32mg, 64mg
Sponsor: Alza Corporation, DE, USA
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module